Dr. Kim Kamdar serves as a Partner at Domain Associates. She is a Co-Founder and serves as Chairman at Seraphina Therapeutics. She serves as Advisory Board Member at Adjuvant Capital. She serves as Board Member at Epitel. She serves as Managing Partner at Medical Excellence Capital. She also serves as Board Member at San Diego Venture Group, Neothetics, Singular Genomics, Epic Sciences, Chairperson of Nominating and Corporate Governance Committee, and Member of Compensation Committee at Obalon Therapeutics. She served as Board Member at Omniome and Aspen Neuroscience. She is a Co-Founder of Truvian Sciences and also serves as its Board Member. She joined Domain in 2005 and became a partner in 2011. Prior to joining MPM, she was a research director at Novartis. She received her B.A. from Northwestern University and her Ph.D. in biochemistry and genetics from Emory University. She serves as an advisory board member of Eric Topol's NIH-supported Clinical and Translational Science Award for Scripps Medicine and of Evolvence India Life Sciences Fund, a private equity fund providing growth capital to Indian pharmaceutical and biotechnology companies.